HeimBOIRF • OTCMKTS
add
Boiron SA
Við síðustu lokun
28,50 $
Árabil
28,50 $ - 46,22 $
Markaðsvirði
488,94 m. EUR
Meðalmagn
34,00
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
EPA
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(EUR) | jún. 2024info | Breyting á/á |
---|---|---|
Tekjur | 114,17 m. | -4,81% |
Rekstrarkostnaður | 77,02 m. | -4,80% |
Nettótekjur | 1,67 m. | -78,46% |
Hagnaðarhlutfall | 1,46 | -77,36% |
Hagnaður á hvern hlut | — | — |
EBITDA | 11,37 m. | -3,88% |
Virkt skatthlutfall | 25,19% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(EUR) | jún. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 53,33 m. | -77,04% |
Heildareignir | 557,65 m. | -25,92% |
Heildarskuldir | 184,68 m. | -8,91% |
Eigið fé alls | 372,97 m. | — |
Útistandandi hlutabréf | 17,36 m. | — |
Eiginfjárgengi | 1,33 | — |
Arðsemi eigna | 3,06% | — |
Ávöxtun eigin fjár | 4,40% | — |
Peningaflæði
Breyting á handbæru fé
(EUR) | jún. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 1,67 m. | -78,46% |
Handbært fé frá rekstri | 6,77 m. | -17,50% |
Reiðufé frá fjárfestingum | -5,09 m. | 24,82% |
Reiðufé frá fjármögnun | -13,23 m. | -36,19% |
Breyting á handbæru fé | -11,36 m. | -22,93% |
Frjálst peningaflæði | 5,75 m. | -7,44% |
Um
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
Stofnsett
7. jún. 1932
Vefsvæði
Starfsfólk
2.788